New Key Statistics Module, Z-Score and F-Score
TSX:ATE Key Ratios
Market Cap C$ M | 15.64 |
Enterprise Value C$ M | -39.17 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.60 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.35 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 3.90 |
5-y EBITDA Growth Rate % | 2.40 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 2.15 |
EV-to-EBITDA | 2.15 |
PEG | -- |
Shares Outstanding M | 53.01 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 10.06 |
Current Ratio | 10.06 |
ROA % (ttm) | -28.31 |
ROE % (ttm) | -53.35 |
ROIC % (ttm) | -68.45 |
Dividend Yield % | -- |
Altman Z-Score | -- |
TSX:ATE Number of Guru Trades
TSX:ATE Volume of Guru Trades
Gurus Latest Trades with TSX:ATE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:ATE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Antibe Therapeutics Inc Insider Transactions
No Available Data